Schrodinger, Inc.·4

Feb 10, 5:00 PM ET

Farid Ramy 4

4 · Schrodinger, Inc. · Filed Feb 10, 2023

Insider Transaction Report

Form 4
Period: 2023-02-09
Farid Ramy
DirectorPresident & CEO
Transactions
  • Award

    Stock Option (right to buy)

    2023-02-09+65,52565,525 total
    Exercise: $25.62Exp: 2033-02-09Common Stock (65,525 underlying)
  • Award

    Stock Option (right to buy)

    2023-02-09+84,96084,960 total
    Exercise: $23.29Exp: 2033-02-09Common Stock (84,960 underlying)
Footnotes (2)
  • [F1]The option was granted on February 9, 2023. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.
  • [F2]The option was granted on February 9, 2023. The exercise price per share is equal to 110% of the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.

Documents

1 file
  • 4
    wf-form4_167606643944365.xmlPrimary

    FORM 4